Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Parkinson Disease Patients Trial N/A Unknown May 9, 2023
Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate Trial Phase 4 Completed May 9, 2023
Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease Trial Phase 1 Completed May 8, 2023
Impact of Customized Respiratory Training on Cardiopulmonary Function in Parkison's Disease Trial N/A Unknown May 8, 2023
Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole Trial Phase 1 Terminated May 5, 2023
A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD Trial Phase 3 Completed May 5, 2023
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers Trial Phase 1 Completed May 5, 2023
Rhythmic Auditory Stimulation on Neural Activity During Finger-tapping in PD Patients Trial N/A Unknown May 2, 2023
Optimising Community Resources and Support to Enhance Living With Parkinson's Disease Trial N/A Completed April 30, 2023
Association Between Fibrinogen-to-albumin Ratio and Delirium After Deep Brain Stimulation Surgery in Parkinson's Disease Trial N/A Completed April 30, 2023
Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Parkinson's Disease Trial N/A Completed April 26, 2023
Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's Trial Phase 1 Withdrawn April 26, 2023